Short oligo are small nucleotide chains typically 20-30 nucleotides in length. Short oligos are synthesized using a solid-phase synthesis method in which the nucleotides are added sequentially to a solid support, with each addition protected by a chemical group to prevent unwanted reactions. The protected oligonucleotides are then cleaved from the support and deprotected to produce the final product. The efficiency and quality of the synthesis depends on many factors, including the choice of solid support, coupling reagents, and deprotection conditions.
BOC Sciences offers a wide range of oligonucleotide synthesis options, and we also offer oligo pool synthesis for customers with large-scale oligonucleotide programs. With extensive experience in the field of synthetic biology, BOC Sciences is a trusted partner for all your synthetic biology needs.
Fig 1. Synthesis of short oligo. (Jadhav et al., 2012)
BOC Sciences offers a range of short oligonucleotide synthesis development services to meet the specific needs of our customers. Our team of experienced scientists work closely with our customers to optimize the synthesis process and ensure high-quality results. We offer a variety of solid supports, coupling reagents and deprotection conditions to meet different applications and requirements.
The experimental process for short oligonucleotide synthesis typically involves the following steps:
a) Design - The sequence of the oligonucleotide is designed according to the specific application and requirements.
b) Synthesis - Oligonucleotides are synthesized using solid-phase synthesis methods, where each nucleotide is added sequentially to a solid-phase support and protected with a chemical moiety.
c) Cleavage - The oligonucleotides are cleaved from the solid phase support and deprotected to obtain the final product.
d) Purification - Oligonucleotides are purified by HPLC or other methods to remove impurities and ensure high purity.
e) Analysis - The purity, identity and quality of the oligonucleotides are confirmed using analytical methods such as HPLC and mass spectrometry.
Synthesis of short oligonucleotides can be challenging due to the difficulty in obtaining high yields and purity. However, BOC Sciences has developed many strategies to overcome these challenges and produce high-quality oligonucleotides. The following are the advantages of short oligo synthesis preparation.
BOC Sciences, as a supplier of products and services for oligonucleotides, can customize professional solutions for our clients. If you are interested in our services, please feel free to contact us.
Reference
GMP Oligonucleotide Manufacturing Service
For more than 15 years, BOC Sciences has been manufacturing oligonucleotides for pre-clinical, pharmaceutical, food safety, and animal health industries. We provide customized and flexible oligonucleotide GMP or non-GMP production services to meet different production needs.
Lipid Nanoparticle(LNP) for RNA Delivery
BOC Sciences offers comprehensive LNP- mRNA delivery services tailored to meet the specific needs of mRNA vaccine development. Our expertise in nanoparticle formulation and mRNA chemistry enables us to design custom LNP formulations optimized for stability, efficacy, and safety.
BOC Sciences promises to offer you with GalNAc-siRNA conjugation services to help you conduct further research on GalNAc-siRNA conjugates and explore their mores omnics capabilities, the working mechanism as well as their potential therapeutic profiles.
BOC Sciences offers aptamer customization services to generate high-quality aptamers tailored to your goals, delivering excellent results even for the most difficult target molecules.
Peptide-Oligonucleotide Conjugation
BOC Sciences is committed to providing our customers with comprehensive modification and labeling, offering affordable custom oligonucleotides or peptide-oligonucleotide conjugates.